Massive study to uncover how obesity and diabetes speed up liver damage
NCT ID NCT07534046
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows over 4,300 adults with compensated advanced chronic liver disease to see how metabolic disorders like obesity, diabetes, and high cholesterol affect disease progression. Participants receive standard care and are monitored every 3 to 6 months for up to 5 years. No experimental treatments are given. The goal is to build a risk prediction model that could help personalize care and prevent serious complications like liver failure or cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better ways to predict serious liver complications and identify new targets for treatment.
- What could go wrong
- This is an observational study, so it cannot prove cause and effect. Results may not apply to all populations, and the long follow-up may lead to dropouts.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMPENSATED ADVANCED CHRONIC LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.